800 results found.
Majority of Public Orthopaedic Companies Still on Track for Full-Year Guidance
By Julie A. Vetalice Looking at 3Q17 revenue and reading call transcripts, much was said about unforeseen headwinds that crept in before the close of the year, affecting orthopaedic companies in a variety of ways. Following weather events, oft-cited “softness&rdqu...
OrthoPediatrics to Distribute Bioretec Devices under Private Label
OrthoPediatrics will market Bioretec’s bioresorbable bone and soft tissue fixation implants under its own TorqLoc
Vericel Reports 3Q17 MACI Revenue +19%
Vericel posted 3Q17 orthobiologic revenue of US $9.9MM, +19.3% vs. 3Q16, and YTD revenue of $27.8MM, +6.5% ...
Smith & Nephew 3Q17 Orthopaedic Revenue +3% YoY
ORTHOWORLD estimates Smith & Nephew 3Q17 orthopaedic revenue of US $793.2MM, +3.3% from 3Q16, and YTD revenue of
Wright Medical 3Q17 Revenue +8% YoY
Wright Medical reported 3Q17 revenue of US $170.5MM, +8.4% from 3Q16, and YTD revenue of $527.4MM, +6.0% vs. t...
ConMed Reports 3Q17 Arthroscopy/Soft Tissue Repair Revenue
ConMed posted 3Q17 arthroscopy/soft tissue repair revenue of US $98.6MM, -0.8% vs. 3Q16, and YTD revenue
Zimmer Biomet 3Q17 Orthopaedic Revenue
ORTHOWORLD estimates Zimmer Biomet 3Q17 orthopaedic revenue of US $1,694.5MM, -0.7% from 3Q16, and YTD revenue of $5,346.6MM, +2.3%...
Stryker's 3Q17 Orthopaedic Revenue +4% vs. 3Q16
ORTHOWORLD estimates Stryker’s 3Q17 orthopaedic revenue at US $1,622.4MM, +3.6% from 3Q16, and YTD revenue of $4,853.3M...
Anika Therapeutics 3Q17 Revenue +7% vs. 3Q16
Anika Therapeutics posted 3Q17 orthobiologic revenue of US $24.0MM, +7.0% vs. 3Q16, and year-to-date revenue of
Arthrosurface Acquires Acellular Dermal Technology for Ortho Applications
Arthrosurface acquired IP from WASAS pertaining to an acellular dermal stabilization allograft device that may...
Anika Fully Enrolls Second Phase III CINGAL Trial
Anika Therapeutics completed enrollment in its second pivotal Phase III trial evaluating CINGAL® HA/corticoste...
Smith & Nephew to Acquire Rotation Medical
Smith & Nephew entered into a definitive agreement to acquire Rotation Medical for US $125MM in initial cash. The tra...
DePuy Synthes 3Q17 Orthopaedic Revenue +0.5% YoY
ORTHOWORLD estimates DePuy Synthes’ 3Q17 orthopaedic revenue at US $2,120.6MM, +0.5% vs. 3Q16, with 9 months 2017 revenue of ...
Anika Gains Australia Approval for MONOVISC Viscosupplement
Anika Therapeutics received Australia regulatory approval to market MONOVISC® single-injection viscosupplement for t...
OrthoPediatrics Closes IPO at $59.8 Million
OrthoPediatrics closed its IPO, raising gross proceeds of US $59.8MM.
Surgical Specialties to Distribute Ortho-ATI in Australia, New Zealand
Orthocell appointed Surgical Specialties as exclusive distributor in Australia and New Zealand
Smith & Nephew CEO Announces Retirement; Acquisition Buzz Returns
Smith & Nephew's Chief Executive Officer, Olivier Bohuon, announced his intention to retire by the end of 2018 after seven years in the positio...
Musculoskeletal Transplant Foundation Rebrands as MTF Biologics
Musculoskeletal Transplant Foundation changed its name to MTF Biologics.
CartiHeal Initiates Agili-C Implant IDE Multinational Pivotal Study
CartiHeal enrolled and treated 16 patients in its IDE study of Agili-C™ implants in the...
OrthoPediatrics Launches IPO
OrthoPediatrics launched its initial public offering of 4MM shares of common stock, with a proposed offering price of $12-$14/share...
Subchondral Solutions Receives FDA Clearance for Fenestrated Cannulated Screws
Subchondral Solutions received FDA 510(k) clearance to market the fenestrated, cannulated S4 Screw System&trade...
Mortise Medical Receives FDA Clearance for LigaMetrics Suture Anchor
Mortise Medical received FDA 510(k) clearance to market the LigaMetrics™ Suture Anchor ...
MiMedx Can Launch Phase 3 IND Trial for Achilles Tendonitis
MiMedx received permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® ...
Orthocell Recruits First Patient for Ortho-ATI Shoulder Tendon Study
Orthocell announced recruitment of the first patient in a clinical trial investigating Ortho-ATI
OrthoPediatrics Files to Raise $57.5MM in an IPO
OrthoPediatrics plans to raise US $57.5MM in a proposed initial public offering. 
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2017 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group